Mireca Medicines
Tübingen, DE · 1 known investors
Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.
Founders & leadership
PF
Prof. François Paquet-DurandScientific Founder
BB
Barbara BrunnhuberinChief Executive Officer
Investors · 1
In the news
Frequently asked questions
- What does Mireca Medicines do?
- Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.
- Who founded Mireca Medicines?
- Mireca Medicines was founded by Prof. François Paquet-Durand.
- Who are Mireca Medicines's investors?
- Mireca Medicines's investors include LU Innovation.
- Where is Mireca Medicines headquartered?
- Mireca Medicines is headquartered in Tübingen, DE.